Skip to main content

Alexion Pharmaceuticals, Inc.

ALXNDelisted Jul 21, 2021
Industry
Pharmaceutical Preparations
SEC CIK
0000899866

Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 711 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.

13F holders, Q1 2022

Institutional positions in Alexion Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

ALXN is no longer listed, and 13F filings after Q2 2021 list far fewer holders. See Q2 2021

Institutional holders
1
−1 vs. Q4 2021
Shares held
60
−26 (−30.2%) vs. Q4 2021
Total value
$13.0K
−$1.00K (−7.1%) vs. Q4 2021
New holders
0
0 more added
Sold out
1
0 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ALXN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 1 institution
Q1 2021: 755 institutionsQ2 2021: 711 institutionsQ3 2021: 7 institutionsQ4 2021: 2 institutionsQ1 2022: 1 institutionQ2 2022: 1 institutionQ3 2022: 1 institutionQ4 2022: 1 institutionQ1 2023: 1 institutionQ2 2023: 1 institutionQ3 2023: 1 institutionQ4 2023: 1 institutionQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 1 institutionQ1 2025: 0 institutionsQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 2 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $13.0K
Q1 2021: $31.3BQ2 2021: $39.1BQ3 2021: $823.0KQ4 2021: $14.0KQ1 2022: $13.0KQ2 2022: $13.0KQ3 2022: $16.0KQ4 2022: $13.0KQ1 2023: $13.0KQ2 2023: $13.6KQ3 2023: $10.4KQ4 2023: $8.83KQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $924.0KQ1 2025: $0Q2 2025: $5.52KQ3 2025: $5.79KQ4 2025: $5.40KQ1 2026: $2.16MQ2 2026: $0
Institutions holding ALXN and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20262$2.16M
Q4 20251$5.40K
Q3 20251$5.79K
Q2 20251$5.52K
Q1 20250$0
Q4 20241$924.0K
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20231$8.83K
Q3 20231$10.4K
Q2 20231$13.6K
Q1 20231$13.0K
Q4 20221$13.0K
Q3 20221$16.0K
Q2 20221$13.0K
Q1 20221$13.0K
Q4 20212$14.0K
Q3 20217$823.0K
Q2 2021711$39.1B
Q1 2021755$31.3B

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Alexion Pharmaceuticals, Inc.; share changes are against Q4 2021.

Institutions holding ALXN in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Retirement Group, LLC60$13.0K0.01%00.0%Unchanged
Sierra Capital LLC0$00.00%−26−100.0%Sold out